Mena, M.
Frias-Gomez, J.
Taberna, M.
Quirós, B.
Marquez, S.
Clavero, O.
Baena, A.
Lloveras, B.
Alejo, M.
León, X.
García, J.
Mesía, R.
Bermejo, O.
Bonfill, T.
Aguila, A.
Guix, M.
Hijano, R.
Pavón, M. A.
Torres, M.
Tous, S.
Clèries, R.
Alemany, L.
Funding for this research was provided by:
Departament de Salut, Generalitat de Catalunya (PERIS-2016–2020 SLT002/16/00404 and SLT006/17/76)
Sociedad Española de Oncología Médica
Article History
Received: 26 February 2020
Accepted: 21 July 2020
First Online: 6 August 2020
Competing interests
: RM has received personal fees and non-financial support from Merck, and personal fees from Astra Zeneca and MSD. MT has received scientific advisory board fees, speaker’s fees, travel grants or non-financial support from Merck, Astra Zeneca, Nanobiotics, MSD and Bristol Meyers. Cancer Epidemiology Research Program (LA, MM, JF, SM, ST, BQ, OC, MT, MTo, MP) has received sponsorship for grants from Merck and co, Roche, Reig-jofre, IDT, Seegene, Hologic and GSK. The rest of authors have declared no conflicts of interest.